Wellington Management Group LLP Sells 93,000 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Wellington Management Group LLP trimmed its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 18.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 407,000 shares of the company's stock after selling 93,000 shares during the period. Wellington Management Group LLP owned 0.64% of Guardian Pharmacy Services worth $8,246,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of GRDN. Nuveen Asset Management LLC increased its holdings in shares of Guardian Pharmacy Services by 2.9% in the 4th quarter. Nuveen Asset Management LLC now owns 547,140 shares of the company's stock worth $11,085,000 after acquiring an additional 15,550 shares during the period. Occudo Quantitative Strategies LP bought a new position in Guardian Pharmacy Services in the 4th quarter valued at about $455,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at about $98,000. Lazard Asset Management LLC boosted its position in shares of Guardian Pharmacy Services by 0.5% during the 4th quarter. Lazard Asset Management LLC now owns 190,797 shares of the company's stock valued at $3,865,000 after purchasing an additional 860 shares in the last quarter. Finally, J. Goldman & Co LP boosted its position in shares of Guardian Pharmacy Services by 1.5% during the 4th quarter. J. Goldman & Co LP now owns 762,347 shares of the company's stock valued at $15,445,000 after purchasing an additional 11,263 shares in the last quarter.

Analyst Ratings Changes

Several research analysts have commented on GRDN shares. Truist Financial reiterated a "buy" rating and issued a $28.00 target price (up from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Raymond James set a $28.00 target price on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a report on Wednesday, May 14th. Finally, Wall Street Zen cut shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th.

Guardian Pharmacy Services Price Performance

GRDN traded down $0.28 during trading on Friday, reaching $20.64. 253,651 shares of the stock traded hands, compared to its average volume of 173,026. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $26.91. The stock's 50-day simple moving average is $23.20 and its two-hundred day simple moving average is $22.00.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analysts' expectations of $321.21 million. Analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Insider Activity

In related news, insider Kendall Forbes sold 64,991 shares of the business's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total transaction of $1,310,218.56. Following the transaction, the insider now owns 203,906 shares of the company's stock, valued at approximately $4,110,744.96. The trade was a 24.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director William E. Bindley sold 651,454 shares of the business's stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total transaction of $13,133,312.64. Following the transaction, the director now directly owns 1,939,817 shares in the company, valued at $39,106,710.72. This trade represents a 25.14% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,344,912 shares of company stock valued at $228,713,426 over the last 90 days. 63.71% of the stock is currently owned by company insiders.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.